Announcements Trials
Browse Landscape

Status

Completed 2Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 13Observational 5

Sponsor

Cancer Type

Tumor-Agnostic 2Gastrointestinal 2Breast 1

Conditions

Pancreatic Neoplasms 2Neoplasms 2Neoplasm Metastasis 1Motor Activity 1Mobility Limitation 1Breast Neoplasms 1

Interventions

Surveys and Questionnaires 543Blood Specimen Collection 446Surgical Procedures, Operative 164Observation 152Drug Therapy 142Radiotherapy 141Interviews as Topic 139Gene Expression Profiling 129Biopsy 117Magnetic Resonance Spectroscopy 116Immunohistochemistry 112Data Collection 95Polymerase Chain Reaction 87Specimen Handling 81Amplified Fragment Length Polymorphism Analysis 81Bevacizumab 78Microarray Analysis 76Flow Cytometry 69Neoadjuvant Therapy 68Watchful Waiting 66Magnetic Resonance Imaging 65Immune Checkpoint Inhibitors 61Nivolumab 60Immunotherapy 57Therapeutics 55Reverse Transcriptase Polymerase Chain Reaction 52pembrolizumab 50Ultrasonography 47Positron Emission Tomography Computed Tomography 47Hematologic Tests 46

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Observational × Fitness Trackers × Clear all
NCT05583890 2025-06-04

PanCanCGM

Lancaster University

Completed
29 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT03757182 2024-08-27

DigiSTEPS

Cedars-Sinai Medical Center

Active not recruiting
80 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT03635723 2024-04-11

BRACELET

Imperial College London

Unknown
75 enrolled
Breast

Breast Neoplasms, Motor Activity, Mobility Limitation

NCT04400903 2022-11-22

Monitoring Heart Rate Variability for the Early Detection of Pancreatic Cancer

OHSU Knight Cancer Institute

Terminated
110 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02659358 2017-09-25

Evaluating the Use of Wearable Biosensors and PROs to Assess Performance Status in Patients With Cancer

Cedars-Sinai Medical Center

Completed
37 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡